Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- GM103Phase 21 trial
GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer
- GNS561Phase 21 trial
Genfit · Cholangiocarcinoma
- GSK4418959Phase 21 trial
GSK · Neoplasms, Colorectal, Solid Tumor, Colon Cancer
- GSK4524101Phase 21 trial
GSK · Neoplasms
- GSK5458514Phase 21 trial
GSK · Neoplasms, Prostate
- GSK5460025Phase 21 trial
GSK · Neoplasms, Colorectal, Neoplasms
- GSK5471713Phase 21 trial
GSK · Neoplasms, Prostate
- GSK5864399Phase 21 trial
GSK · Solid Tumours
- GST101Phase 21 trial
Genuine Seed Therapeutics (Zhuhai) Co., Ltd. · RAS-mutant Advanced Solid Tumors
- GT101Phase 21 trial
Grit Biotechnology · Recurrent or Metastatic Cervical Cancer
- GTAEXS617REC-617Phase 21 trial
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)
- GVV858Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
- HA131Phase 21 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)
- HB-201HB-202 alternating using CD8 PET Tracer, Zr-Df-IAB22M2CPhase 21 trial
Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma
- HB-202Phase 21 trial
Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma
- HB0036Phase 21 trial
Shanghai Huaota Biopharmaceutical Co., Ltd. · Advanced Solid Tumor, NSCLC
- HB0052Phase 21 trial
Shanghai Huaota Biopharmaceutical Co., Ltd. · Solid Tumors
- HCB101Phase 21 trial
FBD Biologics Limited · Solid Cancer
- HCW9218Phase 21 trial
ImmunityBio, Inc. · Advanced Pancreatic Carcinoma
- HG146Phase 21 trial
HitGen Inc. · Adenoid Cystic Carcinoma, Head and Neck Cancer
- HLX53Phase 21 trial
Shanghai Henlius Biotech · Carcinoma, Hepatocellular
- HMBD-001Phase 21 trial
Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma
- HP518Phase 21 trial
Hinova Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer
- HP568Phase 21 trial
Hinova Pharmaceuticals Inc. · Breast Cancer
- HRS-1738Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · PET Imaging in Patients With Prostate Cancer
- HRS-6213Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Patients With Solid Tumors
- HRS-6719Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Advanced/Metastatic Solid Tumors
- HRS-6768Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Advanced Solid Tumors
- HRS-717Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HRS-7172Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HRS-8364Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Solid Tumor
- HRS-9308Phase 21 trial
Chengdu Suncadia Medicine Co., Ltd. · Solid Tumor
- HRX215Phase 21 trial
HepaRegeniX GmbH · Liver Resection, Colorectal Carcinoma Liver Metastases
- HS-10365Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Nonsmall Cell Lung Cancer
- HS-10516Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced Clear Cell Renal Cell Carcinoma
- HS-10566Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · High-risk Non-muscle-invasive Bladder Cancer
- HS-20105Phase 21 trial
Hansoh BioMedical R&D Company · Advanced Solid Tumor
- HSK39775Phase 21 trial
Xizang Haisco Pharmaceutical Co., Ltd · Advanced Solid Tumors
- HSK42360-NaPhase 21 trial
Haisco Pharmaceutical Group Co., Ltd. · Metastatic Colorectal Cancer (CRC)
- HST-1011Phase 21 trial
HotSpot Therapeutics, Inc · Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer
- HX009Phase 21 trial
Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma
- HX044Phase 21 trial
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Advanced Solid Tumor Malignancies
- HX111Phase 21 trial
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Solid Tumor and Lymphoma
- HX301Phase 21 trial
Hangzhou Hanx Biopharmaceuticals, Ltd. · Glioma
- HY-0102Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
- HY05350Phase 21 trial
Sichuan Huiyu Pharmaceutical Co., Ltd · Advanced Solid Tumor
- IAM1363Phase 21 trial
Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer
- IBI129Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor
- IBI133Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Locally Advanced Unresectable or Metastatic Solid Tumors
- IBI3005Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.